Angiotensin II activates MAPK and stimulates growth of human pulmonary artery smooth muscle via AT1 receptors

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 277, Issue 3 21-3, 1999, Pages

  Morrell, Nicholas W ^a   Upton, Paul D ^a   Kotecha, Sailesh ^a   Huntley, Alyson ^a   Yacoub, Magdi H ^b   Polak, Julia M ^c   Wharton, John ^c  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b HAREFIELD HOSPITAL   (United Kingdom)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Angiotensin II type 1 receptors; Mitogen activated protein kinase; Pulmonary hypertension; Vascular remodeling

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; LOSARTAN; MITOGEN ACTIVATED PROTEIN KINASE;

ARTERY MEDIA; ARTERY MUSCLE; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVATION; HUMAN; HUMAN TISSUE; LIGAND BINDING; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SMOOTH MUSCLE FIBER; TISSUE DISTRIBUTION;

EID: 0032886630     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.1999.277.3.l440     Document Type: Article

References (38)

1. Alpert, M. A., T. A. Pressly, V. Mukerji, C. R. Lambert, and B. Mukerji. Short-and long-term hemodynamic effects of captopril in patients with pulmonary hypertension and selected connective tissue disease. Chest 102: 1407-1412, 1992.
2. Assender, J. W., E. Irenius, and B. B. Fredholm. 5-Hydroxy-tryptamine, angiotensin and bradykinin transiently increase intracellular calcium concentrations and PKC-alpha activity, but do not induce mitogenesis in human vascular smooth muscle cells. Acta Physiol. Scand. 160: 207-217, 1997.
3. Campbell-Boswell, M., and A. L. Robertson. Effects of angiotensin II and vasopressin on human smooth muscle cells in vitro. Exp. Mol. Pathol. 35: 265-276, 1981.
4. Cassis, L. A., P. E. Rippetoe, E. E. Soltis, D. J. Painter, R. Fitz, and M. N. Gillespie. Angiotensin II and monocrotaline-induced pulmonary hypertension: effect of losartan (DuP 753), a nonpeptide angiotensin type 1 receptor antagonist. J. Pharmacol. Exp. Ther. 262:1168-1172, 1992.
5. Dudley, D. T., L. Pang, S. J. Decker, A. J. Bridges, and A. R. Saltiel. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. USA 92: 7686-7689, 1995.
6. Eguchi, S., T. Matsumoto, E. D. Motley, H. Utsunomiya, and T. Inagami. Identification of an essential signaling cascade for mitogen-activated protein kinase activation by angiotensin II in cultured rat vascular smooth muscle cells. J. Biol. Chem. 271: 14169-14175, 1996.
7. Frid, M. G., E. C. Dempsey, A. G. Durmowicz, and K. R. Stenmark. Smooth muscle cell heterogeneity in pulmonary and systemic vessels. Arterioscler. Thromb. Vasc. Biol. 17: 1203-1209, 1997.
8. Frid, M. G., E. P. Moiseeva, and K. R. Stenmark. Multiple phenotypically distinct smooth muscle cell populations exist in the adult and developing bovine pulmonary arterial wall. Circ. Res. 75: 669-681, 1994.
9. Geisterfer, A. A. T., M. J. Peach, and G. K. Owens. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ. Res. 62: 749-756, 1988.
10. Gibbons, G. H., R. E. Pratt, and V. J. Dzau. Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-betal expression determines growth response to angiotensin II. J. Clin. Invest. 90: 456-461, 1992.
11. Hatakeyama, H., I. Miyamori, T. Fujita, Y. Takeda, R. Takeda, and H. Yamamoto. Vascular aldosterone. Biosynthesis and a link to angiotensin II-induced hypertrophy of vascular smooth muscle cells. J. Biol. Chem. 269: 24316-24320, 1994.
12. Jackson, C. L., and S. M. Schwartz. Pharmacology of smooth muscle cell replication. Hypertension 20: 713-736, 1992.
13. Janiak, P., A. Pillon, J.-F. Prost, and J.-P. Vilaine. Role of angiotensin subtype 2 receptors in neointima formation after vascular injury. Hypertension 20: 737-745, 1992.
14. Jovin, T. M., S. J. Morris, G. Striker, H. A. Schultens, M. Digwood, and D. J. Arndt-Jovin. Automatic sizing and separation of particles by ratios of light scattering intensities. J. Histochem. Cytochem. 24: 269-283, 1976.
15. Knock, G. A., M. H. F. Sullivan, A. McCarthy, M. G. Elder, J. M. Polak, and J. Wharton. Angiotensin II (AT1) vascular binding sites in human placentae from normal-term, preeclamptic and growth retarded pregnancies. J. Pharmacol. Exp. Ther. 271: 1007-1015, 1994.
16. Lefroy, D. C., J. Wharton, T. Crake, G. A. Knock, R. A. D. Rutherford, T. Suzuki, K. Morgan, J. M. Polak, and P. A. Poole-Wilson. Regional changes in angiotensin II receptor density after experimental myocardial infarction. J. Mol. Cell. Cardiol. 28: 429-440, 1996.
17. Leier, C. V., D. Bambach, S. Nelson, J. B. Hermiller, P. Huss, R. D. Magorien, and D. V. Unverferth. Captopril in primary pulmonary hypertension. Circulation 67: 155-161, 1983.
18. 1 receptor. J. Hypertens. 10: 1463-1469, 1992.
19. Lyall, F., A. F. Lever, and J. J. Morton. Vascular hypertrophy and hypertension: a role for growth factors? Acta Physiol. Scand. 133: 189-196, 1988.
20. Makita, S., M. Nakamura, H. Yoshida, and K. Hiramori. Effect of angiotensin II receptor blocker on angiotensin II stimulated DNA synthesis of cultured human aortic smooth muscle cells. Life Sci. 56: PL383-PL388, 1995.
21. Mii, S., J. A. Ware, S. A. Mallette, and K. C. Kent. Effect of angiotensin II on human vascular smooth muscle cell growth. J. Surg. Res. 57: 174-178, 1994.
22. Morrell, N. W., E. N. Atochina, K. G. Morris, S. M. Danilov, and K. R. Stenmark. Angiotensin converting enzyme expression is increased in small pulmonary arteries of rats with hypoxia-induced pulmonary hypertension. J. Clin. Invest. 96: 1823-1833, 1995.
23. Morrell, N. W., S. S. Grieshaber, S. M. Danilov, R. A. Majack, and K. R. Stenmark. Developmental regulation of angiotensin converting enzyme and angiotensin type 1 receptor in the rat pulmonary circulation. Am. J. Respir. Cell Mol. Biol. 14: 526-537, 1996.
24. Morrell, N. W., K. G. Morris, and K. R. Stenmark. Role of angiotensin-converting enzyme and angiotensin II in development of hypoxic pulmonary hypertension. Am. J. Physiol. 269 (Heart Circ. Physiol. 38): H1186-H1194, 1995.
25. Naftilan, A. J., G. K. Gilliland, C. S. Eldridge, and A. S. Kraft. Induction of the proto-oncogene c-jun by angiotensin II. Mol. Cell. Biol. 10: 5536-5540, 1990.
26. Okada, K., M. L. Bernstein, W. Zhang, D. P. Schuster, and M. D. Botney. Angiotensin-converting enzyme inhibition delays pulmonary vascular neointimal formation. Am. J. Respir. Crit. Care Med. 158: 939-950, 1998.
27. Sachinidis, A., Y. Ko, W. Nettekoven, A. J. Wieczorek, R. Dusing, and H. Vetter. The effect of angiotensin II on DNA synthesis varies considerably in vascular smooth muscle cells from different Wistar-Kyoto rats. J. Hypertens. 10: 1159-1164, 1992.
28. Schuster, D. P., E. C. Crouch, W. C. Parks, T. Johnson, and M. D. Botney. Angiotensin converting enzyme expression in primary pulmonary hypertension. Am. J. Respir. Crit. Care Med. 154: 1087-1091, 1996.
29. Stoll, M., U. M. Steckelings, M. Paul, S. P. Bottari, R. Metzger, and T. Unger. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J. Clin. Invest. 95: 651-657, 1995.
30. Stumpe, K. O., K. Schmengler, L. Bette, A. Overlack, and R. Kolloch. Persistent hemodynamic and clinical improvement after captopril in patients with pulmonary hypertension. Herz 11: 217-225, 1986.
31. Su, E. J., D. M. Lombardi, J. Wiener, M. J. A. P. Daemen, M. A. Reidy, and S. M. Schwartz. Mitogenic effect of angiotensin II on rat carotid arteries and type II or III mesenteric microvessels but not type I mesenteric microvessels is mediated by endogenous basic fibroblast growth factor. Circ. Res. 82: 321-327, 1998.
32. Van Suylen, R. J., J. F. M. Smits, and M. J. A. P. Daemen. Pulmonary artery remodeling differs in hypoxia-and monocrotaline-induced pulmonary hypertension. Am. J. Respir. Crit. Care Med. 157: 1423-1428, 1998.
33. Viswanathan, M., K. Tsutsumi, F. M. Correa, and J. M. Saavedra. Changes in expression of angiotensin receptor sub-types in the rat aorta during development. Biochem. Biophys. Res. Commun. 179: 1361-1367, 1991.
34. Weber, H., D. S. Taylor, and C. J. Molloy. Angiotensin II induces delayed mitogenesis and cellular proliferation in rat aortic smooth muscle cells. Correlation with the expression of specific endogenous growth factors and reversal by suramin. J. Clin. Invest. 93: 788-798, 1994.
35. Wharton, J., K. Morgan, R. A. D. Rutherford, J. D. Catravas, A. Chester, B. F. Whitehead, M. R. De Leval, M. H. Yacoub, and J. M. Polak. Differential distribution of angiotensin AT2 receptors in the normal and failing human heart. J. Pharmacol. Exp. Ther. 284: 323-336, 1998.
36. Zakheim, R. M., L. Mattioli, A. Molteni, K. B. Mullis, and J. Bartley. Prevention of pulmonary vascular changes of chronic alveolar hypoxia by inhibition of angiotensin I-converting enzyme in the rat. Lab. Invest. 33: 57-61, 1975.
37. Zhao, L., R. Al-Tubuly, A. Sebkhi, A. A. Owji, D. J. R. Nunez, and M. R. Wilkins. Angiotensin II receptor expression and inhibition in the chronically hypoxic rat lung. Br. J. Pharmacol. 119: 1217-1222, 1996.
38. βα subunit, src family, and Ras in cardiac fibroblasts. Circ. Res. 82: 337-345, 1998.